XORTX Therapeutics Inc. (XRTX)
Nasdaq: XRTX · Pharmaceutical Preparations · Vancouver, BC · filing with the SEC since 2018
Who owns XORTX Therapeutics Inc.
As filed with the SECHolders of 5% or more
1
Lincoln Alternative Strategies LLC holds 9.9% of Common Shares, no par value per share, as its SCHEDULE 13G filed Oct 27, 2025 says.
Directors and officers
0
report now, of 0 people on the record since . Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Lincoln Alternative Strategies LLC
SCHEDULE 13G · filed Oct 27, 2025 · Common Shares, no par value per share
Armistice Capital, LLC
SCHEDULE 13G/A · filed May 15, 2025 · Common shares, no par value per share · reported falling below 5%, from 9.99% in Feb 14, 2025
What XRTX reports owning in othersstakes of 5% or more, and other ties
XORTX Therapeutics Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.